Investor Relations

Corporate Governance

Investor Relations

Corporate Governance

Board of Directors Committees Internal Audit Organization Major Internal Policies
Board Members Major Board Resolutions Board Performance Evaluation Report Information on the Election of Independent Directors Communication Between Independent Directors and the Head of Internal Audit and CPAs

Information on the Election of Independent Directors

Nomination and Election Method

Under the Articles of Incorporation, there shall be no fewer than two independent directors among the directors, and they shall make up no less than one-fifth of the board seats. All directors are elected under the candidate nomination system. In addition, pursuant to Article 192-1 of the Company Act, the Company stated in its announcement of February 26, 2026 convening the Annual General Meeting that independent directors for this term would be elected under the candidate nomination system, and that shareholders holding 1% or more of the Company's total issued shares may submit a list of independent director candidates to the Company in writing. Shareholders wishing to nominate independent directors are asked to send, by registered mail or delivery to the Company (address: 5F, No. 167, Fuxing N. Rd., Taipei City 105) between March 3 and March 13, 2026, the nominee's name, education, and experience, a letter of undertaking to serve as director if elected, a declaration that none of the circumstances in Article 30 of the Company Act apply, and other relevant supporting documents.

Nomination Process and Candidate Information

During this period, the only candidates were the four independent director candidates nominated and approved by the Company's Board of Directors on February 24, 2026. All four meet the qualifications for independent directors, and on the same day the Company announced the list of independent director candidates for this term in accordance with the law, as follows:

Independent Director Candidate Education Experience Current Position Shares Held
Hui-Yu Chen
  • Department of Animal Science, National Taiwan University
  • Vice Chairman, Choice Development, Inc.
  • Independent Director, Hengping Co., Ltd.
  • Director, Microloops Corp.
  • Independent Director, Senao Networks, Inc.
  • Independent Director, Maywufa Company Ltd.
  • Chairman, Choice Development, Inc.
  • Representative of Institutional Director, TransGlobe Life Insurance Inc.
  • Chairman, Life Insurance Association of the Republic of China
  • Independent Director, TaiRx, Inc.
  • Independent Director, TECO Electric & Machinery Co., Ltd.
  • Director, Shihlin Development Co., Ltd.
 0 shares
Shu-Fang Ou
  • Ph.D. in Biomedical Engineering, Jinan University, Guangzhou
  • MBA, China Europe International Business School (CEIBS)
  • Department of Chinese and Western Medicine, China Medical University
  • Industry Advisor, NTU Innovation and Incubation Center
  • Reviewing Physician, Executive Committee of the National Health Insurance Primary Care Global Budget Payment System, Taiwan Medical Association
  • Ophthalmologist, Cardinal Tien Hospital
  • Ophthalmologist, Taipei Municipal Zhongxiao Hospital
  • Ophthalmologist, Cathay General Hospital
  • Ophthalmologist, National Taiwan University Hospital
  • Independent Director, Maywufa Company Ltd.
  • Chairman, Universal Vision Biotechnology Co., Ltd.
  • Independent Director, Gudeng Precision Industrial Co., Ltd.
  • Vice Chairman, National Association of Small and Medium Enterprises
  • Director, Ten Outstanding Young Persons Foundation
  • Honorary President, Corporate Directors Chapter, Global Federation of Chinese Business Women
  • Honorary Executive Director, Global Federation of Chinese Business Women
  • Chairman, Taipei Neihu Technology Park Development Association
  • Vice Chairman, Taiwan Tai-Fu Innovation Association
  • Vice Chairman, NTU E-Shih-Pan Alumni Association
  • Director, World Taiwanese Chambers of Commerce
  • Director, Taiwan Society of Ophthalmic Visual Optics and Refractive Optometry
  • Director, NTU Industry-Academia Development Association
Hong-Jen Chang
  • M.S. in Health Policy and Management, Harvard School of Public Health, USA
  • Master of Public Health, National Taiwan University
  • M.D., National Yang-Ming Medical College
  • Deputy Minister, Department of Health, Executive Yuan
  • President, Bureau of National Health Insurance
  • Director-General, Centers for Disease Control, Department of Health, Executive Yuan
  • Adjunct Professor, Institute of Public Health, National Yang Ming Chiao Tung University
  • Director, Medeon Biodesign, Inc.
  • Representative of Institutional Director, Taiwania Capital Management Corporation
  • President, Taiwan Global BioFund (TGB)
  • Chairman and Vice Chairman, Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA)
  • Director, Abprotix Inc.
  • Lifemax Healthcare International Corporation, Director
  • Representative of Institutional Director, CASI Biotechnology (Suzhou) Co., Ltd.
  • Director, AmMax Bio Inc.
  • Representative of Institutional Director, Jiangsu KMQ Biotechnology Co., Ltd. (KMQ)
  • Representative of Institutional Director, Sequential Medicine Limited
  • Director, Acepodia Biotech, Inc.
  • Director, Excelsior Biopharma Inc.
  • Representative of Institutional Director, Taiwania Biotech Co., Ltd.
  • Director, Formosa Pharmaceuticals, Inc.
  • Independent Director, TOT Biopharm Co., Ltd. (Mainland China)
  • Independent Director, Maywufa Company Ltd.
  • Chairman and President, Shang Teng Biotech Consulting Co., Ltd.
  • Chairman, Shang Zhun Microfluidics Co., Ltd.
  • Chairman, Micareo, Inc.
  • Chairman, Ya Hsiang Biotech and Pharmaceutical Co., Ltd.
  • Chairman, Hsiang Yung Biotech Management Consulting Co., Ltd.
  • Representative of Institutional Director, TaiGen Biopharmaceuticals Holdings Limited
  • Representative of Institutional Director, TaiGen Biotechnology Co., Ltd.
  • Representative of Institutional Director, Universal Vision Biotechnology Co., Ltd.
  • Director, Taiwan Cultural and Creative Angel Investment Co., Ltd.
 0 shares
Chi-Feng Lin
  • M.S. in Management Science, Baker University, Kansas, USA
  • Assistant Vice President, Citibank Taiwan
  • Assistant Vice President, First Trust and Investment Co., Ltd. (Taiwan)
  • Vice President, CIGNA Life Insurance Company, Taiwan Branch
  • President, Fubon Direct Marketing Consulting Co., Ltd.
  • Chairman / President, momo.com Inc.
  • Independent Director, Maywufa Company Ltd.
  • Senior Advisor, momo.com Inc.
  • Director, Cheng Hsi Information Integration Co., Ltd.
  • Representative of Institutional Director, Li Tong Biomedical Technology Co., Ltd.
  • Vice Chairman, Taiwan Enterprise Reengineering Management Consulting Co., Ltd.
  • Chairman, World Vision Taiwan
 0 shares

Election Results

At the Company's Annual General Meeting on June 10, 2026,
four independent directors were nominated: Hui-Yu Chen, Shu-Fang Ou, Hong-Jen Chang, and Chi-Feng Lin. The election results are as follows:

Name Votes Received Election Results
Hui-Yu Chen 55,102,494 votes Elected
Shu-Fang Ou 54,029,511 votes Elected
Hong-Jen Chang 52,481,905 votes Elected
Chi-Feng Lin 51,310,894 votes Elected